Atossa Therapeutics's total assets for Q3 2024 were $79.48M, a decrease of -7.43% from the previous quarter. ATOS total liabilities were $5.80M for the fiscal quarter, a 1.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.